Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Azenta Azta Stock Priced For Growth Price At 22.64 Down 0.07 20260410 Is Wheaton Wpm Stock Priced For Growth Price At 145.31 Up 3.14 20260410 Can Ferguson Enterprises Ferg Stock Rebound In 2026 Price At 249.81 Up 5.89 20260408 Will Park Ha Bio Byah Stock Miss Expectations Price At 1.02 Down 2.86 20260406 What News Is Impacting Electromed Elmd Stock Price At 23.78 Up 0.72 20260408 Is BioVie BIVI stock showing bullish signals today BioVie Inc Delivers 135 Percent EPS Beat Topping Analyst Estimates Cognition CGTX Stock Extended Hours Technical Strength 20260416 What Illinois ITW does better than 90 of companies 030 20260508 Phillips 66 PSX Q1 2026 Earnings Analysis Margin Strength Offsets Profit Compression as Dividend Commitment Remains Intact Is Capital One COF building a durable competitive moat Flirts with Support 20260511 Broadcom Inc AVGO Poised for LongTerm Upside Amid Explosive AI Infrastructure Spending Tailwinds Global X Social Media ETF SOCL Positioned for Catalyst Upside Amid Baidus Historic Capital Return Announcement How Toll Brothers TOL revenue breaks down and what it means Investor Concern 20260511 Union Pacific Corporation UNP Reports Solid Operational Efficiency Aligns With FullYear Guidance in Q1 2026 Earnings Release Is UMB UMBFO stock weak today UMB posts 195 percent EPS beat topping analyst estimates handily Why BuzzFeed BZFD financial health is stronger than most think 487 20260503 Why SBA SBAC is a smarter play than most realize 049 20260506 Is Olenox Industries OLOX stock a smart investment Q3 2023 EPS Exceeds Expectations ANIP ANI Pharma smashes Q4 estimates with 438 revenue surge but shares dip despite beat Gold Slips to 112Month Low Amid Middle East Tensions and Rate Outlook Uncertainty Technical Outlook Points to Bullish Momentum in Intermediate Term Opendoor OPENL Slips 216 Testing 026 Support 20260515 Nvidia Earnings Call in Focus Geopolitical Commentary on China Chips and Trump Trade Policy Under Scrutiny AI Is Reshaping the American Dream Skilled Trade Workers Stand to Gain Western SBI Stock Jumps 051 Approaching 823 20260514 Lufthansa Secures Majority Control of ITA Airways in 325 Million Deal CNH Industrial NV Surges in Q1 What Drove the Rally Target Beats Q1 Forecasts Shares Dip as Cost Pressures Mount Spotify Shares Surge on AI Music Partnership with Universal Music Group and Upbeat Guidance Chinas DeepSeek AI Claims Breakthrough HighPerformance Models Trained at Low Cost Without TopTier Chips KOSPI Surges 84 Amid Samsung Strike Suspension and Nvidia Earnings Boost Singapores MAS Aims to Accelerate Private Banking Account Openings to Under One Month SP Global Inc Analyst Report Market Assessment and Sector Outlook Integrated Customer Engagement Adding Digital Horsepower to the Brand Flywheel Traders Shift Expectations Fed Rate Hike Now Seen as Next Move After Inflation Data The Mandalorian and Grogu May Mark Disneys Weakest Star Wars Box Office Opening Emerson Electric EMR Q1 2026 Earnings Narrow Earnings Miss Masks Resilience Stock Rises Allegion ALLE Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges Scienture Holdings Inc SCNX Q1 2026 Earnings EPS Surprise of 64 Narrows Loss Amid Strategic Progress EONR Q2 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress VRM Q3 2025 Earnings Continued Losses Amid Strategic Pivot Alerus Financial ALRS Sees Modest Decline Amidst Broader Financial Sector Pressures Fifth Era Acquisition Corp I Rights FERAR Holds at 030 as Support and Resistance Converge Dutch Bros BROS Slides 25 as Coffee Chain Faces Resistance at 5473 OS Therapies OSTX Tests Support as Shares Decline Nearly 5 GT The shares tumble 79 despite EPS beat investors eye revenue concerns and cost pressures BVFL BV Financial posts 52 percent year over year Q1 2026 revenue growth shares dip 106 percent ABX Abacus Global shares climb 385 despite flat earnings investors eye managements upbeat secondhalf outlook Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market YSS York Space shares tumble 13 as Q4 2025 EPS comes in 26 below consensus analyst estimates